APOE and Alzheimer disease: In 2014, Besser et al. observed that weight loss of >4% was associated with faster clinical progression in participants with amnestic mild cognitive impairment (aMCI) and higher disease severity in AD; however, the observation only applied to participants with non-APOE ε4 alleles [15].